The Chief Executive Officer of the Food and Drugs Authority (FDA), Dr Delese Darko, has announced that the agency has granted licenses to a total of 10,038 products under the Progressive Licensing Scheme (PLS) since its launch in 2019.
Also, she noted that the FDA had registered 1,900 facilities under the scheme.
The PLS, which was established by the FDA in 2019, aims to improve the quality, safety, wholesomeness, and efficacy of products regulated by the FDA, thereby promoting public health and sustainable development.
Speaking at a workshop in Accra last Wednesday, Dr Darko said the PLS was established to support the government industrialisation agenda. In 2020, the FDA Boss said under the PLS programme, about 80 small business owners were trained and 2,400 products were registered.
